Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|September 10, 2005
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse modelEric Nuermberger, Sandeep Tyagi, Kathy N Williams, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2013
Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosisZahoor Ahmad, Sandeep Tyagi, Austin Minkowski, et al.
Plos Neglected Tropical Diseases|January 20, 2011
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in miceDeepak Almeida, Paul J Converse, Zahoor Ahmad, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisEric Nuermberger, Sandeep Tyagi, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinationsClaire Andréjak, Deepak V Almeida, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse modelAmy Sarah Ginsburg, Ronggai Sun, Heather Calamita, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2012
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapyClaire Andréjak, Deepak V Almeida, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infectionsZahoor Ahmad, Mostafa M Fraig, Gregory P Bisson, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge systemAmy Sarah Ginsburg, Jin Lee, Samuel C Woolwine, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infectionTianyu Zhang, Si-Yang Li, Paul J Converse, et al.
Pageof 6